We are live on
!
Find out more
Denali Therapeutics
DNLI
DNLI
210 hedge funds and large institutions have $6.31B invested in Denali Therapeutics in 2021 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 81 increasing their positions, 59 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
290% more call options, than puts
Call options by funds: $30M | Put options by funds: $7.7M
37% more capital invested
Capital invested by funds: $4.59B → $6.31B (+$1.72B)
37% more repeat investments, than reductions
Existing positions increased: 81 | Existing positions reduced: 59
0.03% more ownership
Funds ownership: 66.51% → 66.54% (+0.03%)
3% less funds holding
Funds holding: 216 → 210 (-6)
13% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 39
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Holders
210
Holders Change
-6
Holders Change %
-2.78%
% of All Funds
3.66%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.07%
New
34
Increased
81
Reduced
59
Closed
39
Calls
$30M
Puts
$7.7M
Net Calls
+$22.3M
Net Calls Change
+$18.6M
Top Buyers
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$133M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$33.8M |
| 3 |
BlackRock
New York
|
+$29.2M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$22.1M |
| 5 |
State Street
Boston,
Massachusetts
|
+$18.8M |
Top Sellers
| 1 |
CM
Crestline Management
Fort Worth,
Texas
|
-$114M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$71.4M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$32.3M |
| 4 |
Two Sigma Investments
New York
|
-$17.2M |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$16.3M |
